NISCH and adenocarcinoma: Taken together, high level of NISCH expression was not a universal marker of good prognosis in cancer patients, not even within the same tumor group (such are adenocarcinomas BRCA, COAD, PAAD, LUAD, etc.), as it was previously postulated.